Avricore Grants Options
VANCOUVER, British Columbia, May 15, 2023 (GLOBE NEWSWIRE) — AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 1,625,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.28 per common share.
Related news for (AVCRF)
- AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
- Avricore Health Corporate Update and Audited Results for 2023
- HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations
- Avricore Health Corporate Update – Company Demonstrates Strong Growth
- HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic